Jun 25, 2020 8:30am EDT Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
Jun 10, 2020 1:30pm EDT Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jun 08, 2020 8:00am EDT Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jun 03, 2020 8:00am EDT Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program
Apr 23, 2020 7:30am EDT Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020
Apr 09, 2020 4:01pm EDT Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
